SuperworthEloxx Pharmaceuticals shares outstanding ELOX
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 6.8M
- On a year earlier
- +1856.5%
- more shares
Eloxx Pharmaceuticals had 6.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1856.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2023 | 285.8K | +45% |
| FY2022 | 196.9K | +0% |
| FY2021 | 196.3K | +115% |
| FY2020 | 91.3K | +0% |
| FY2019 | 91K | +14% |
| FY2018 | 80.1K | +738% |
| FY2017 | 9.6K | −42% |
| FY2017 | 16.5K | +610% |
| FY2016 | 2.3K | +28% |
| FY2015 | 1.8K | +54% |
| FY2014 | 1.2K | +484% |
| FY2013 | 202 | +90% |
| FY2012 | 107 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 6.8M | +1857% | |
| Q1 FY26 | 4.4M | +1167% | |
| Q2 FY25 | 347K | n/a | |
| Q1 FY25 | 346K | n/a | |
| Q4 FY23 | 285.8K | +45% | |
| Q3 FY23 | 249.8K | +27% | |
| Q2 FY23 | 201.1K | +2% | |
| Q1 FY23 | 196.9K | +0% | |
| Q4 FY22 | 196.9K | +0% | |
| Q3 FY22 | 196.9K | +1% | |
| Q2 FY22 | 196.9K | +31% | |
| Q1 FY22 | 196.9K | +116% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Eloxx Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.